INDSWFTLTDNSEInd-Swift Limited· PharmaceuticalsHighNeutral
Announced Thu, 29 May · 18:13 IST

Ind-Swift Limited has informed the Exchange about update on second motion petition for approval of Scheme of Arrangement

Nclt Scheme FiledStrategic Transactions View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Limited has informed the stock exchange about an update regarding the second motion petition filed for approval of its Scheme of Arrangement. A second motion petition is filed with the National Company Law Tribunal (NCLT) after the first motion and shareholder/creditor meetings are concluded, seeking the tribunal's final approval. The filing itself does not disclose specifics of the scheme such as swap ratio, type of arrangement, or counterparty details. This is a procedural update indicating the company is progressing through the NCLT approval process.

Likely market impact

This is a procedural regulatory update and is unlikely to have an immediate material impact on the stock price. Shareholders should await further disclosures detailing the nature, ratio, and timeline of the proposed scheme to assess its true impact on share value.